Orphan/rare drug discovery through drug repositioning

Ramaiah Muthyala

doi:10.1016/j.ddstr.2011.10.003

ScienceGate Book Chapters

JOURNAL ARTICLE

Orphan/rare drug discovery through drug repositioning

Ramaiah Muthyala

Year: 2011 Journal: Drug Discovery Today Therapeutic Strategies Vol: 8 (3-4)Pages: 71-76 Publisher: Elsevier BV

DOI: 10.1016/j.ddstr.2011.10.003

Get Full-Text PDF Get Analytical Report

Keywords:

Incentive Orphan drug Government (linguistics) Drug Business Drug discovery Drug repositioning Internet privacy Medicine Pharmacology Computer science Economics Bioinformatics Biology

Metrics

Cited By

1.39

FWCI (Field Weighted Citation Impact)

Refs

0.82

Citation Normalized Percentile

Is in top 1%

Is in top 10%

Citation History

Topics

Biotechnology and Related Fields

Health Sciences → Medicine → Public Health, Environmental and Occupational Health

Pharmaceutical Economics and Policy

Social Sciences → Economics, Econometrics and Finance → Economics and Econometrics

Genomics and Rare Diseases

Life Sciences → Biochemistry, Genetics and Molecular Biology → Genetics

Orphan/rare drug discovery through drug repositioning

Metrics

Citation History

Topics

Related Documents

Drug repositioning strategies for rare and orphan diseases

Drug discovery technologies to achieve pain relief through drug repositioning approaches

Drug Repositioning: An Approach for Drug Discovery

Drug Repositioning: A Faster Path to Drug Discovery

Reverse pharmacology and drug repositioning in drug discovery